Cash flow Roche Holding AG Swiss Exchange

Stocks

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:30:07 09/06/2026 BST			5-day change	1st Jan Change
318.80 ^CHF	-1.21%		+1.67%	-2.86%

01:49am	Samsung Elec invests $175 million to become top shareholder in US genetics firm	RE
06-09	Health Care Up Amid Multibillion Dollar Oncology Deals - Health Care Roundup	DJ

31bc19536c17cfabbf6980c3f5299f0.Ht9jNENLf2YNQg5lukwqI0-MiTvqGGtKsYZ0cGzr6Ag.SqkUGXUSOTllJDsW9i5kbiPa4Ai6XjMw1-c5IAKlr2ZRnjp4diw7I2gkSw

Published financial data: ROCHE HOLDING AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	65.85B	66.43B	58.72B	60.5B	61.52B
Other Revenues, Total	-	-	1.72B	1.9B	1.84B
Total Revenues	65.85B	66.43B	60.44B	62.4B	63.36B
Cost of Goods Sold, Total	19.36B	18.6B	15.6B	15.73B	16.16B
Gross Profit	46.49B	47.83B	44.84B	46.66B	47.19B
Selling General & Admin Expenses, Total	11.98B	12.05B	13.49B	13.67B	13.77B
R&D Expenses	14.02B	14.4B	13.54B	13.37B	12.54B
Other Operating Expenses	238M	192M	34M	1M	-66M
Other Operating Expenses, Total	26.24B	26.64B	27.06B	27.05B	26.24B
Operating Income	20.25B	21.19B	17.78B	19.62B	20.96B
Interest Expense, Total	-342M	-608M	-828M	-1.25B	-1.19B
Interest And Investment Income	-	40M	195M	260M	203M
Net Interest Expenses	-342M	-568M	-633M	-988M	-984M
Income (Loss) On Equity Invest.	-2M	-41M	-32M	-45M	-30M
Currency Exchange Gains (Loss)	-232M	-278M	-243M	-291M	-273M
Other Non Operating Income (Expenses)	3M	-90M	-14M	-20M	5M
EBT, Excl. Unusual Items	19.68B	20.21B	16.86B	18.27B	19.68B
Restructuring Charges	-1.36B	-969M	-2.04B	-1.89B	-2.16B
Merger & Related Restructuring Charges	-55M	38M	-25M	-43M	-21M
Impairment of Goodwill	-	-	-591M	-3.21B	-40M
Gain (Loss) On Sale Of Investments	-89M	-85M	5M	35M	-14M
Gain (Loss) On Sale Of Assets	-	-	569M	384M	141M
Asset Writedown	-634M	-2.87B	-637M	-1.47B	-390M
Legal Settlements	-122M	45M	172M	-83M	-177M
Other Unusual Items	-20M	-43M	-233M	-199M	-38M
EBT, Incl. Unusual Items	17.4B	16.33B	14.08B	11.79B	16.97B
Income Tax Expense	2.46B	2.8B	1.72B	2.61B	3.17B
Earnings From Continuing Operations	14.94B	13.53B	12.36B	9.19B	13.8B
Net Income to Company	14.94B	13.53B	12.36B	9.19B	13.8B
Minority Interest	-1B	-1.11B	-860M	-910M	-919M
Net Income - (IS)	13.93B	12.42B	11.5B	8.28B	12.88B
Net Income to Common Incl Extra Items	13.93B	12.42B	11.5B	8.28B	12.88B
Net Income to Common Excl. Extra Items	13.93B	12.42B	11.5B	8.28B	12.88B
Per Share Items
Net EPS - Basic	16.39	15.53	14.39	10.39	16.18
Basic EPS - Continuing Operations	16.39	15.53	14.39	10.39	16.18
Basic Weighted Average Shares Outstanding	850M	800M	799M	797M	796M
Net EPS - Diluted	16.2	15.37	14.31	10.31	16.04
Diluted EPS - Continuing Operations	16.2	15.37	14.31	10.31	16.04
Diluted Weighted Average Shares Outstanding	860M	808M	804M	802M	803M
Normalized Basic EPS	13.29	14.4	12.11	13.19	14.29
Normalized Diluted EPS	13.13	14.26	12.03	13.11	14.17
Dividend Per Share	9.3	9.5	9.6	9.7	9.8
Payout Ratio	55.8	59.95	66.01	92.42	60.02
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	24.33B	24.69B	20.92B	22.72B	24.04B
EBITA	21.81B	22.12B	18.5B	20.36B	21.63B
EBIT	20.25B	21.19B	17.78B	19.62B	20.96B
EBITDAR	24.42B	24.78B	21B	22.8B	24.11B
Total Revenues (As Reported)	65.85B	66.43B	60.44B	62.4B	63.36B
Effective Tax Rate - (Ratio)	14.16	17.12	12.22	22.1	18.7
Total Current Taxes	2.62B	4.45B	2.83B	4.32B	3.37B
Total Deferred Taxes	-156M	-1.66B	-1.11B	-1.72B	-196M
Normalized Net Income	11.3B	11.52B	9.68B	10.51B	11.38B
Interest on Long-Term Debt	24M	20M	31M	49M	50M
Non-Cash Pension Expense	23M	45M	123M	119M	115M
Supplemental Operating Expense Items
Selling and Marketing Expenses	9.48B	9.58B	-	-	-
General and Administrative Expenses	2.42B	2.39B	-	-	-
Research And Development Expense From Footnotes	14.8B	16.02B	14.2B	15.3B	13.35B
Net Rental Expense, Total	87M	87M	82M	80M	69M
Imputed Operating Lease Interest Expense	9.92M	14.28M	18.88M	23.76M	18.83M
Imputed Operating Lease Depreciation	77.08M	72.72M	63.12M	56.24M	50.17M
Stock-Based Comp., COGS (Total)	106M	106M	86M	94M	99M
Stock-Based Comp., R&D Exp. (Total)	277M	330M	385M	394M	387M
Stock-Based Comp., S&M Exp. (Total)	140M	155M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	140M	147M	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	359M	367M	371M
Total Stock-Based Compensation	663M	738M	830M	855M	857M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.85B	4.99B	5.38B	6.98B	5.58B
Short Term Investments	6.18B	4.78B	5.13B	10.34B	9.89B
Trading Asset Securities, Total	4M	1M	2M	16M	10M
Total Cash And Short Term Investments	13.03B	9.77B	10.51B	17.33B	15.49B
Accounts Receivable, Total	11.35B	12.21B	11.55B	11.92B	11.96B
Other Receivables	1.23B	1.43B	1.32B	1.47B	1.88B
Notes Receivable	45M	33M	55M	66M	61M
Total Receivables	12.63B	13.67B	12.92B	13.46B	13.91B
Inventory	7.72B	8.6B	7.75B	7.61B	7.48B
Prepaid Expenses	1.87B	1.2B	1.14B	1.22B	1.25B
Restricted Cash	23M	198M	61M	22M	129M
Other Current Assets, Total	359M	376M	1.06B	387M	473M
Total Current Assets	35.63B	33.82B	33.45B	40.04B	38.73B
Gross Property Plant And Equipment	48.2B	49.41B	46.2B	49.38B	48.37B
Accumulated Depreciation	-23.79B	-25.2B	-23.26B	-25.64B	-25.44B
Net Property Plant And Equipment	24.41B	24.21B	22.94B	23.74B	22.93B
Long-term Investments	1.07B	971M	789M	858M	805M
Goodwill	10.81B	10.82B	9.39B	7.88B	7.49B
Other Intangibles, Total	12.12B	9.68B	14.83B	17.3B	19.32B
Accounts Receivable Long-Term	36M	26M	19M	31M	33M
Loans Receivable Long-Term	7M	7M	7M	7M	6M
Deferred Tax Assets Long-Term	5.58B	6.43B	6.88B	8.57B	8.41B
Other Long-Term Assets, Total	2.66B	2.19B	2.17B	3.38B	2.97B
Total Assets	92.32B	88.15B	90.47B	102B	101B
Liabilities
Accounts Payable, Total	4.12B	4.13B	3.78B	4.35B	5.28B
Accrued Expenses, Total	9.11B	12.25B	11.43B	12.8B	12.27B
Short-term Borrowings	500M	1.76B	848M	180M	783M
Current Portion of Long-Term Debt	14.62B	2.36B	3.62B	3.78B	3.43B
Current Portion of Leases	329M	302M	291M	325M	311M
Current Income Taxes Payable	3B	3.19B	2.26B	2.92B	2.87B
Unearned Revenue Current, Total	560M	601M	614M	809M	792M
Other Current Liabilities	6.18B	2.65B	1.98B	1.86B	2.28B
Total Current Liabilities	38.42B	27.24B	24.82B	27.02B	28B
Long-Term Debt	16.08B	21.39B	24.81B	30.72B	27.43B
Long-Term Leases	1.02B	891M	1.28B	1.38B	1.24B
Unearned Revenue Non Current	246M	254M	227M	160M	116M
Pension & Other Post Retirement Benefits	6.1B	4.56B	4.38B	4.38B	3.95B
Deferred Tax Liability Non Current	628M	645M	593M	832M	884M
Other Non Current Liabilities	1.48B	1.16B	1.09B	1.15B	1.2B
Total Liabilities	63.97B	56.14B	57.2B	65.64B	62.82B
Common Stock, Total	160M	107M	107M	107M	107M
Retained Earnings	34.16B	38.94B	42.35B	43.84B	48.84B
Comprehensive Income and Other	-9.83B	-11.05B	-13.14B	-12.18B	-15.14B
Total Common Equity	24.49B	27.99B	29.32B	31.77B	33.8B
Minority Interest	3.86B	4.02B	3.95B	4.39B	4.08B
Total Equity	28.34B	32.02B	33.26B	36.16B	37.88B
Total Liabilities And Equity	92.32B	88.15B	90.47B	102B	101B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	800M	799M	797M	795M	796M
ECS Total Common Shares Outstanding	800M	799M	797M	795M	796M
Book Value / Share	30.6	35.03	36.77	39.94	42.49
Tangible Book Value	1.56B	7.49B	5.1B	6.59B	6.99B
Tangible Book Value Per Share	1.95	9.37	6.39	8.28	8.78
Total Debt	32.55B	26.7B	30.85B	36.38B	33.2B
Net Debt	19.52B	16.93B	20.34B	19.05B	17.71B
Debt Equivalent of Unfunded Proj. Benefit Obligation	4B	1.59B	1.94B	1.74B	-116M
Debt Equivalent Oper. Leases	696M	696M	656M	640M	552M
Minority Interest, Total (Incl. Fin. Div)	3.86B	4.02B	3.95B	4.39B	4.08B
Equity Method Investments, Total	331M	300M	242M	258M	258M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.55B	1.95B	1.7B	1.61B	1.46B
Inventories - Work In Process, Total	5.84B	6.39B	5.62B	5.12B	5B
Inventories - Finished Goods, Total	1.2B	1.14B	1.18B	1.57B	1.74B
Land - (BS)	1.32B	1.25B	1.11B	1.16B	1.28B
Buildings, Total	18.18B	19.81B	17.93B	20.67B	19.88B
Machinery, Total	16.36B	16.78B	14.36B	15.11B	14.7B
Full Time Employees	101K	104K	104K	103K	-
Assets on Operating Lease - Gross	5.64B	5.72B	5.56B	6.05B	6.21B
Assets on Operating Lease - Accumulated Depreciation	-4.01B	-4.16B	-3.98B	-4.26B	-4.22B
Accumulated Allowance for Doubtful Accounts (Supple)	538M	490M	440M	453M	351M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	13.93B	12.42B	11.5B	8.28B	12.88B
Depreciation & Amortization - CF	2.89B	2.91B	2.75B	2.68B	2.71B
Amortization of Goodwill and Intangible Assets - (CF)	1.56B	938M	716M	742M	676M
Depreciation & Amortization, Total	4.44B	3.84B	3.46B	3.42B	3.39B
Amortization of Deferred Charges, Total - (CF)	8M	4M	8M	9M	8M
(Gain) Loss From Sale Of Asset	-496M	-612M	-558M	-616M	-43M
(Gain) Loss on Sale of Investments - (CF)	89M	85M	-5M	-35M	14M
Asset Writedown & Restructuring Costs	1.45B	2.89B	2.23B	5.74B	1.41B
(Income) Loss On Equity Investments - (CF)	2M	41M	32M	45M	30M
Stock-Based Compensation (CF)	663M	738M	830M	855M	857M
Provision and Write-off of Bad Debts	44M	3M	6M	34M	14M
Other Operating Activities, Total	1.84B	1.42B	-305M	1.2B	1.95B
Change in Other Net Operating Assets	-994M	-2.42B	-1.11B	1.16B	-1.66B
Cash from Operations	20.98B	18.42B	16.1B	20.09B	18.85B
Capital Expenditure	-3.69B	-3.45B	-3.74B	-3.53B	-3.75B
Sale of Property, Plant, and Equipment	61M	82M	173M	61M	139M
Cash Acquisitions	-2.36B	-245M	-6.22B	-3.12B	-3.08B
Divestitures	7M	1M	559M	1.43B	59M
Sale (Purchase) of Intangible assets	-856M	-1.1B	-907M	-1.48B	-2.03B
Investment in Marketable and Equity Securities, Total	363M	1.13B	-707M	-5B	32M
Other Investing Activities, Total	-73M	51M	201M	246M	82M
Cash from Investing	-6.55B	-3.54B	-10.64B	-11.39B	-8.54B
Short Term Debt Issued, Total	-	1.29B	-	-	656M
Long-Term Debt Issued, Total	20.31B	8.44B	8.34B	7.92B	2.58B
Total Debt Issued	20.31B	9.74B	8.34B	7.92B	3.23B
Short Term Debt Repaid, Total	-1.13B	-	-806M	-709M	-
Long-Term Debt Repaid, Total	-2.83B	-15.84B	-2.09B	-3.74B	-3.75B
Total Debt Repaid	-3.96B	-15.84B	-2.9B	-4.45B	-3.75B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-20.4B	-1.26B	-1.14B	-1.13B	-987M
Common Dividends Paid	-7.77B	-7.45B	-7.59B	-7.65B	-7.73B
Common & Preferred Stock Dividends Paid	-7.77B	-7.45B	-7.59B	-7.65B	-7.73B
Other Financing Activities, Total	-1.29B	-1.47B	-951M	-1.51B	-2.13B
Cash from Financing	-13.11B	-16.28B	-4.24B	-6.82B	-11.37B
Foreign Exchange Rate Adjustments	-193M	-463M	-828M	-283M	-334M
Net Change in Cash	1.12B	-1.86B	385M	1.6B	-1.39B
Supplemental Items
Cash Interest Paid	405M	557M	770M	1.14B	1.19B
Cash Income Tax Paid (Refund)	3.34B	4.1B	3.62B	3.73B	3.14B
Levered Free Cash Flow	12.89B	11.32B	8.6B	13.67B	11.03B
Unlevered Free Cash Flow	13.1B	11.69B	9.11B	14.44B	11.76B
Change In Net Working Capital	116M	1.58B	1.64B	-2.91B	-197M
Net Debt Issued / Repaid	16.35B	-6.1B	5.45B	3.47B	-519M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	14.19	14.68	12.44	12.75	12.94
Return on Total Capital	21.81	22.14	18.09	17.94	18.24
Return On Equity %	43.85	44.83	37.86	26.47	37.27
Return on Common Equity	45.8	47.34	40.13	27.1	39.29
Margin Analysis
Gross Profit Margin %	70.6	72	74.19	74.79	74.49
SG&A Margin	18.19	18.14	22.31	21.92	21.73
EBITDA Margin %	36.95	37.17	34.61	36.41	37.95
EBITA Margin %	33.12	33.31	30.6	32.63	34.15
EBIT Margin %	30.76	31.9	29.42	31.44	33.08
Income From Continuing Operations Margin %	22.68	20.37	20.45	14.72	21.78
Net Income Margin %	21.15	18.7	19.02	13.27	20.33
Net Avail. For Common Margin %	21.15	18.7	19.02	13.27	20.33
Normalized Net Income Margin	17.15	17.34	16.01	16.85	17.96
Levered Free Cash Flow Margin	19.58	17.04	14.24	21.9	17.41
Unlevered Free Cash Flow Margin	19.89	17.6	15.08	23.14	18.56
Asset Turnover
Asset Turnover	0.74	0.74	0.68	0.65	0.63
Fixed Assets Turnover	2.76	2.73	2.56	2.67	2.71
Receivables Turnover (Average Receivables)	6.02	5.64	4.94	5.15	5.15
Inventory Turnover (Average Inventory)	2.6	2.28	1.91	2.05	2.14
Short Term Liquidity
Current Ratio	0.93	1.24	1.35	1.48	1.38
Quick Ratio	0.67	0.86	0.94	1.14	1.05
Operating Cash Flow to Current Liabilities	0.55	0.68	0.65	0.74	0.67
Days Sales Outstanding (Average Receivables)	60.67	64.73	73.83	71	70.87
Days Outstanding Inventory (Average Inventory)	140.54	160.15	191.36	178.63	170.34
Average Days Payable Outstanding	71.17	77.23	98	95.51	109.59
Cash Conversion Cycle (Average Days)	130.04	147.64	167.19	154.11	131.61
Long Term Solvency
Total Debt/Equity	114.84	83.4	92.75	100.6	87.64
Total Debt / Total Capital	53.45	45.47	48.12	50.15	46.71
LT Debt/Equity	60.33	69.6	78.44	88.76	75.7
Long-Term Debt / Total Capital	28.08	37.95	40.7	44.25	40.34
Total Liabilities / Total Assets	69.3	63.68	63.23	64.48	62.38
EBIT / Interest Expense	59.22	34.85	21.47	15.72	17.66
EBITDA / Interest Expense	72.21	41.17	25.66	18.46	20.51
(EBITDA - Capex) / Interest Expense	61.41	35.5	21.14	15.63	17.35
Total Debt / EBITDA	1.32	1.07	1.45	1.58	1.36
Net Debt / EBITDA	0.79	0.68	0.96	0.83	0.73
Total Debt / (EBITDA - Capex)	1.55	1.24	1.76	1.86	1.61
Net Debt / (EBITDA - Capex)	0.93	0.78	1.16	0.98	0.86
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.13	0.87	-8.16	3.23	1.54
Gross Profit, 1 Yr. Growth %	4.51	2.88	-6.33	4.06	1.14
EBITDA, 1 Yr. Growth %	1.82	1.47	-13.1	8.6	5.84
EBITA, 1 Yr. Growth %	1.69	1.45	-14	10.08	6.26
EBIT, 1 Yr. Growth %	2.82	4.61	-13.56	10.34	6.84
Earnings From Cont. Operations, 1 Yr. Growth %	-0.88	-9.4	-8.67	-25.66	50.2
Net Income, 1 Yr. Growth %	-2.55	-10.83	-7.43	-28.01	55.61
Normalized Net Income, 1 Yr. Growth %	1.34	1.99	-13.11	8.63	8.26
Diluted EPS Before Extra, 1 Yr. Growth %	-1.99	-5.1	-6.9	-27.95	55.58
Accounts Receivable, 1 Yr. Growth %	7.72	7.52	-5.4	3.25	0.34
Inventory, 1 Yr. Growth %	7.24	11.54	-9.95	-1.85	-1.67
Net Property, Plant and Equip., 1 Yr. Growth %	4.91	-0.84	-5.24	3.49	-3.4
Total Assets, 1 Yr. Growth %	7.17	-4.51	2.63	12.53	-1.08
Tangible Book Value, 1 Yr. Growth %	-89.63	379.01	-31.92	29.25	6.09
Common Equity, 1 Yr. Growth %	-32.61	14.3	4.73	8.36	6.41
Cash From Operations, 1 Yr. Growth %	12.98	-12.21	-9.59	24.85	-6.18
Capital Expenditures, 1 Yr. Growth %	4.68	-6.61	8.5	-5.69	6.21
Levered Free Cash Flow, 1 Yr. Growth %	53.17	-12.08	-21.29	58.83	-19.31
Unlevered Free Cash Flow, 1 Yr. Growth %	50.87	-10.59	-19.4	58.41	-18.53
Dividend Per Share, 1 Yr. Growth %	2.2	2.15	1.05	1.04	1.03
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.63	4.92	-4.2	-2.63	2.38
Gross Profit, 2 Yr. CAGR %	0.13	3.69	-1.79	-1.27	2.59
EBITDA, 2 Yr. CAGR %	-1.29	1.64	-7.28	-2.86	7.21
EBITA, 2 Yr. CAGR %	-1.69	1.57	-7.91	-2.71	8.15
EBIT, 2 Yr. CAGR %	-1.87	3.71	-6.31	-2.34	8.57
Earnings From Cont. Operations, 2 Yr. CAGR %	2.89	-5.24	-9.04	-17.6	5.67
Net Income, 2 Yr. CAGR %	1.59	-6.78	-9.15	-18.37	5.84
Normalized Net Income, 2 Yr. CAGR %	-3.21	1.67	-7.45	-2.84	8.44
Diluted EPS Before Extra, 2 Yr. CAGR %	1.83	-3.55	-6	-18.1	5.87
Accounts Receivable, 2 Yr. CAGR %	2.22	7.62	0.86	-1.17	1.79
Inventory, 2 Yr. CAGR %	12.88	9.37	0.22	-5.98	-1.76
Net Property, Plant and Equip., 2 Yr. CAGR %	2.32	2	-3.06	-0.97	-0.01
Total Assets, 2 Yr. CAGR %	5.41	1.16	-1.01	7.46	5.51
Tangible Book Value, 2 Yr. CAGR %	-63.45	-29.53	80.58	-6.2	17.1
Common Equity, 2 Yr. CAGR %	-13.52	-12.24	9.41	6.53	7.38
Cash From Operations, 2 Yr. CAGR %	-3.2	-0.41	-12.4	6.24	8.23
Capital Expenditures, 2 Yr. CAGR %	2.68	-1.13	0.66	1.15	0.08
Levered Free Cash Flow, 2 Yr. CAGR %	-4.92	15.95	-18.25	11.81	13.21
Unlevered Free Cash Flow, 2 Yr. CAGR %	-5.4	16.05	-16.52	13	13.6
Dividend Per Share, 2 Yr. CAGR %	1.65	2.17	1.6	1.05	1.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.44	1.38	0.05	-1.78	-1.26
Gross Profit, 3 Yr. CAGR %	2.65	1.04	0.27	0.12	-0.48
EBITDA, 3 Yr. CAGR %	2.64	-0.38	-4.34	-2.26	-0.04
EBITA, 3 Yr. CAGR %	2.57	-0.65	-4.82	-2.27	0.2
EBIT, 3 Yr. CAGR %	2.3	0.24	-3.36	-1.06	0.63
Earnings From Cont. Operations, 3 Yr. CAGR %	11.19	-1.38	-6.4	-14.95	0.66
Net Income, 3 Yr. CAGR %	9.88	-2.73	-7	-15.93	1.22
Normalized Net Income, 3 Yr. CAGR %	0.97	-1.5	-4.61	-2.37	0.72
Diluted EPS Before Extra, 3 Yr. CAGR %	9.88	-0.53	-4.68	-13.98	1.43
Accounts Receivable, 3 Yr. CAGR %	3.48	3.96	3.09	1.65	-0.67
Inventory, 3 Yr. CAGR %	5.23	12.43	2.51	-0.47	-4.57
Net Property, Plant and Equip., 3 Yr. CAGR %	3.82	1.26	-0.48	-0.93	-1.79
Total Assets, 3 Yr. CAGR %	5.55	1.99	1.65	3.31	4.54
Tangible Book Value, 3 Yr. CAGR %	-44.87	-13.83	-30.33	61.53	-2.27
Common Equity, 3 Yr. CAGR %	-3.93	-5.1	-6.91	9.06	6.49
Cash From Operations, 3 Yr. CAGR %	1.64	-6.3	-4.65	-1.42	1.93
Capital Expenditures, 3 Yr. CAGR %	-2.97	-0.52	1.98	-1.5	2.81
Levered Free Cash Flow, 3 Yr. CAGR %	1.37	-7.42	0.73	2.01	0.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.92	-7.21	1.63	3.35	1.32
Dividend Per Share, 3 Yr. CAGR %	2.25	1.82	1.8	1.41	1.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.58	3.57	0.32	-0.43	0.98
Gross Profit, 5 Yr. CAGR %	4.36	3.71	0.85	0.13	1.19
EBITDA, 5 Yr. CAGR %	3.33	3.11	-1.45	-1.88	0.12
EBITA, 5 Yr. CAGR %	3.2	3.1	-1.76	-2.04	0.17
EBIT, 5 Yr. CAGR %	3.75	4.14	-1.24	-1.38	1.25
Earnings From Cont. Operations, 5 Yr. CAGR %	8.94	8.92	2.61	-8.22	-1.74
Net Income, 5 Yr. CAGR %	7.78	7.55	1.83	-9.32	-2.06
Normalized Net Income, 5 Yr. CAGR %	2.84	2.51	-2.48	-2.71	0.41
Diluted EPS Before Extra, 5 Yr. CAGR %	7.78	8.9	3.23	-7.97	-0.59
Accounts Receivable, 5 Yr. CAGR %	5.61	3.93	2.42	1.87	2.57
Inventory, 5 Yr. CAGR %	-0.54	3.04	3.2	4.67	0.78
Net Property, Plant and Equip., 5 Yr. CAGR %	4.11	2.97	1.01	0.36	-0.29
Total Assets, 5 Yr. CAGR %	3.74	2.83	2.87	4.15	3.17
Tangible Book Value, 5 Yr. CAGR %	21.8	-1.31	-11.39	-10.85	-14.25
Common Equity, 5 Yr. CAGR %	0.48	1.15	1.2	-0.61	-1.44
Cash From Operations, 5 Yr. CAGR %	6.94	0.43	-4.23	-2.14	0.31
Capital Expenditures, 5 Yr. CAGR %	-2.28	-0.34	-1.54	0.15	1.22
Levered Free Cash Flow, 5 Yr. CAGR %	9.2	-1.78	-7.01	-0.85	5.55
Unlevered Free Cash Flow, 5 Yr. CAGR %	8.46	-1.7	-6.49	-0.27	6.26
Dividend Per Share, 5 Yr. CAGR %	2.55	2.74	1.99	1.51	1.49